![Daniel Calkins](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 679 980 $ al 31/07/2026
Daniel Calkins is currently Chief Financial Officer & Vice President-Finance at Verastem, Inc., a position held since 2023.
Education history includes graduate studies at Northeastern University and undergraduate studies at Bryant University.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
VERASTEM, INC. 0,19 % | 22/06/2026 | 117.238 ( 0,19 % ) | 679 980 $ | 31/07/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| VERASTEM, INC. | Director Financiero/CFO | 31/10/2022 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 3 |
|---|---|
Northeastern University
 Northeastern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bryant University
 Bryant University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Verastem, Inc.
 Verastem, Inc. BiotechnologyHealth Technology Discovers and develops drugs | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
